XML 39 R21.htm IDEA: XBRL DOCUMENT v3.3.1.900
Risk Management And Derivatives
12 Months Ended
Jan. 30, 2016
General Discussion of Derivative Instruments and Hedging Activities [Abstract]  
Risk Management And Derivatives
12.    RISK MANAGEMENT AND DERIVATIVES


General Risk Management
The Company maintains cash and cash equivalents and certain other financial instruments with various financial institutions. The financial institutions are located throughout the world and the Company’s policy is designed to limit exposure to any one institution or geographic region. The Company’s periodic evaluations of the relative credit standing of these financial institutions are considered in the Company’s investment strategy.

The Company’s Brand Portfolio segment sells to national chains, department stores, online retailers, mass merchandisers, independent retailers and catalogs in the United States, Canada and approximately 65 other countries. Receivables arising from these sales are not collateralized. However, a portion is covered by documentary letters of credit. Credit risk is affected by conditions or occurrences within the economy and the retail industry. The Company maintains an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers and historical trends.

Derivatives
In the normal course of business, the Company’s financial results are impacted by currency rate movements in foreign-currency-denominated assets, liabilities and cash flows as it makes a portion of its purchases and sales in local currencies. The Company has established policies and business practices that are intended to mitigate a portion of the effect of these exposures. The Company uses derivative financial instruments, primarily forward contracts, to manage its currency exposures. These derivative financial instruments are viewed as risk management tools and are not used for trading or speculative purposes. Derivatives entered into by the Company are designated as cash flow hedges of forecasted foreign currency transactions.

Derivative financial instruments expose the Company to credit and market risk. The market risk associated with these instruments resulting from currency exchange movements is expected to offset the market risk of the underlying transactions being hedged. The Company does not believe there is a significant risk of loss in the event of non-performance by the counterparties associated with these instruments because these transactions are executed with major international financial institutions and have varying maturities through January 2017. Credit risk is managed through the continuous monitoring of exposures to such counterparties.

The Company principally uses foreign currency forward contracts as cash flow hedges to offset a portion of the effects of exchange rate fluctuations. The Company’s cash flow exposures include anticipated foreign currency transactions, such as foreign currency denominated sales, costs, expenses and intercompany charges, as well as collections and payments. The Company performs a quarterly assessment of the effectiveness of the hedge relationship and measures and recognizes any hedge ineffectiveness in the consolidated statement of earnings. Hedge ineffectiveness is evaluated using the hypothetical derivative method. The amount of hedge ineffectiveness for 2015, 2014 and 2013 was not material.

The Company’s hedging strategy uses forward contracts as cash flow hedging instruments, which are recorded in the Company’s consolidated balance sheets at fair value. The effective portion of gains and losses resulting from changes in the fair value of these hedge instruments are deferred in accumulated other comprehensive income and reclassified to earnings in the period that the hedged transaction is recognized in earnings.

As of January 30, 2016 and January 31, 2015, the Company had forward contracts maturing at various dates through January 2017 and January 2016, respectively. The contract amount represents the net amount of all purchase and sale contracts of a foreign currency.

(U.S. $ equivalent in thousands)
 
January 30, 2016

 
January 31, 2015

Financial Instruments
 
 
 
 
U.S. dollars (purchased by the Company’s Canadian division with Canadian dollars)
 
$
14,118

 
$
19,633

Euro
 
15,499

 
16,152

Chinese yuan
 
14,623

 
14,512

Japanese yen
 
1,159

 
1,523

United Arab Emirates dirham
 
930

 
970

New Taiwanese dollars
 
570

 
599

Other currencies
 
219

 

Total financial instruments
 
$
47,118

 
$
53,389



The classification and fair values of derivative instruments designated as hedging instruments included within the consolidated balance sheets as of January 30, 2016 and January 31, 2015 are as follows:

($ in thousands)
Asset Derivatives
 
Liability Derivatives
 
Balance Sheet Location
Fair Value
 
 
Balance Sheet Location
Fair Value
 
Foreign exchange forwards contracts:
 
 
 
 
 
 
January 30, 2016
Prepaid expenses and other current assets
 
$
1,000

 
Other accrued expenses
 
$
846

January 31, 2015
Prepaid expenses and other current assets
 
$
1,863

 
Other accrued expenses
 
$
1,784




During 2015 and 2014, the effect of derivative instruments in cash flow hedging relationships on the consolidated statements of earnings was as follows:

 
 
2015
 
2014
Foreign exchange forward contracts:
Income Statement Classification
Gains (Losses) - Realized
 
Gain (Loss)
Recognized in
OCI on
Derivatives

 
Gain (Loss) Reclassified
from Accumulated
OCI into Earnings

 
Gain (loss)
Recognized in
OCI on
Derivatives

 
Gain (loss) Reclassified
from Accumulated
OCI into Earnings

Net sales
 
$
57

 
$
147

 
$
166

 
$
93

Cost of goods sold
 
1,028

 
(27
)
 
(693
)
 
113

Selling and administrative expenses
 
(907
)
 
(297
)
 
(271
)
 
(64
)
Interest expense
 
(17
)
 

 
18

 



All of the gains and losses currently included within accumulated other comprehensive (loss) income associated with the Company’s foreign exchange forward contracts are expected to be reclassified into net earnings within the next 12 months. Additional information related to the Company’s derivative financial instruments are disclosed within Note 1 and Note 13 to the consolidated financial statements.